• 1998

Company Description

Noxxon Pharma develops biostable aptamers and substances based on mirror image nucleic acids.

NOXXON Pharma AG, a biopharmaceutical company, develops biostable aptamers and substances based on mirror image nucleic acids. Its Spiegelmer is a mirror image oligonucleotide therapeutic for the pharmacologically relevant target. The company has a strategic alliance with Pfizer, Inc. NOXXON Pharma AG was founded in 1997 and is based in Berlin, Germany.

  • Manufacturer:

    Science and Engineering
  • Formed:

    1998
  • Company Website:

  • Company E-mail:

  • Company Address:

    Max-Dohrn-Str. 8-10
    Berlin
    Germany
  • CEO:

    • Frank Morich
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits